Company intelligence / Profile preview
El Dorado Biotech
- Ownership
- Private
- Development stage
- Other
Overview
El Dorado Biotech is an integrated healthcare solutions provider based in India, specializing in chronic therapy areas. Established in 2002, the company focuses on manufacturing and marketing generic pharmaceutical formulations across cardiovascular, anti-diabetic, and gastrointestinal segments. It maintains a significant commercial presence in India with a portfolio of over 10 therapeutic areas.
- Therapeutic areas
- EndocrinologyCardiovascularNeurologyInfectious DiseasesPulmonologyGastroenterology
- Modalities
- Small molecule
- Industry
- Biotech
Drug pipeline
8 assets7 more assets in the full pipeline.
Beyond the preview
Go deeper on El Dorado Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on El Dorado Biotech.